Medifast, Inc., the parent company of OPTAVIA, announced that its Board of Directors has declared a $1.13 quarterly cash dividend to its stockholders. This dividend will be payable on February 5, 2021. “Medifast’s growth this year has been strong given the uncertain economic conditions driven by the COVID-19 pandemic,” says Dan Chard, Medifast Chief Executive […]
Medifast, Inc. reported revenue increased 42.8 percent for the third quarter ended September 30, 2020. Third quarter revenue increased was $271.5 million compared to $190.1 million for the third quarter of 2019. OPTAVIA-branded products represented 83.0 percent of consumable units sold for the third quarter compared to 78.0 percent for the same period a year ago. The total number of active earning OPTAVIA Coaches […]
Medifast, Inc. announced it was ranked second on FORTUNE© Magazine’s list of the top 100 Fastest-Growing Companies. FORTUNE’s 2020 100 Fastest-Growing Companies list measures and ranks corporations by revenue growth rate, EPS growth rate and three-year annualized total return for the period ending June 30, 2020. The publication positions the list as an indicator of forces driving the […]
Medifast hosted its second annual Healthy Habits for All Week, a week of service dedicated to helping underserved communities adopt healthy habits through improved education and access. From Monday, Sept. 21 through Sunday, Sept. 27, 2020, Medifast empowered its global community to donate and volunteer to promote healthy habit creation in their local communities. “While Healthy Habits for All […]
Medifast announced that it has appointed Lauren Walker as executive vice president, Supply Chain Operations, effective Sept. 21, 2020. In her role, Walker will be responsible for overseeing Medifast’s global supply chain organization. As a key member of the company’s leadership team, she will report directly to Chief Executive Officer Dan Chard. “Over the last few […]
Medifast, the company behind OPTAVIA®, reported revenue of $220.0 million for the second quarter ended June 30, 2020. Second quarter revenue increased 17.6% to $220.0 million from revenue of $187.1 million for the second quarter of 2019. OPTAVIA-branded products represented 83 percent of consumable units sold for the second quarter compared to 75 percent for the same period a year ago. […]
Medifast recently hosted a new live broadcast event experience, OPTAVIA Together Live, replacing its traditional in-person convention, which was cancelled due to the global pandemic. The international event, streamed July 24–26, attracted more than 50,000 registrants from across the globe. The presentations generated more than 140,000 views on Facebook, as Coaches hosted watch parties and live events on […]
Medifast, Inc. announced that it has appointed James (Jim) Maloney as chief financial officer, effective today. In his role, Maloney will be responsible for leading the finance function, including all aspects of financial planning and analysis, setting Medifast’s financial and capital allocation strategies and managing investor relations. He will serve as a member of the […]
Nearly nine out of ten U.S. adults (88%) report experiencing stress during the pandemic, according to a survey conducted by Medifast. Additionally, 82 percent of those surveyed are concerned about at least one aspect of their physical or mental health, and one-fifth are struggling to make progress on their pre-pandemic health goals. Medifast, the company behind OPTAVIA®, surveyed […]
Medifast (NYSE: MED), the company behind the health and wellness community OPTAVIA®, reported results for the first quarter ended March 31, 2020. First quarter revenue increased 7.6 percent to $178.5 million from revenue of $165.9 million for the first quarter of 2019. OPTAVIA-branded products represented 79 percent of consumable units sold for the first quarter compared to 73 percent for the same period […]
Medifast (NYSE: MED) yesterday reported revenue increased 17 percent in the fourth quarter and 42.4 percent for the full year ended December 31, 2019. Fourth quarter revenue increased to $170.6 million from revenue of $145.8 million for the fourth quarter of 2018. OPTAVIA-branded products represented 79 percent of consumable units sold for the fourth quarter compared […]
Medifast (NYSE: MED) yesterday reported revenue increased 17 percent in the fourth quarter and 42.4 percent for the full year ended December 31, 2019. Fourth quarter revenue increased to $170.6 million from revenue of $145.8 million for the fourth quarter of 2018. OPTAVIA-branded products represented 79 percent of consumable units sold for the fourth quarter compared […]